Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women
Clinical trial NCT01721993 · COMPLETED
Trial details
- NCT number
- NCT01721993
- Sponsor
- Thar Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-07-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.